Hyperosmolar hyperglycemic state secondary prevention: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hyperosmolar hyperglycemic state}} | {{Hyperosmolar hyperglycemic state}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{HS}} | ||
==Overview== | ==Overview== |
Revision as of 21:39, 27 September 2017
Hyperosmolar hyperglycemic state Microchapters |
Differentiating Hyperosmolar hyperglycemic state from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hyperosmolar hyperglycemic state secondary prevention On the Web |
American Roentgen Ray Society Images of Hyperosmolar hyperglycemic state secondary prevention |
FDA on Hyperosmolar hyperglycemic state secondary prevention |
CDC on Hyperosmolar hyperglycemic state secondary prevention |
Hyperosmolar hyperglycemic state secondary prevention in the news |
Blogs on Hyperosmolar hyperglycemic state secondary prevention |
Risk calculators and risk factors for Hyperosmolar hyperglycemic state secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]
Overview
Secondary prevention of hyperosmolar hyperglycemic state (HHS) is similar to primary prevention.
Secondary Prevention
- Secondary prevention of hyperosmolar hyperglycemic state (HHS) is similar to primary prevention.